Thorac Cardiovasc Surg 2017; 65(S 02): S111-S142
DOI: 10.1055/s-0037-1598978
DGPK Oral Presentations
Sunday, February 12, 2017
DGPK: Basic Science and Clinical Studies
Georg Thieme Verlag KG Stuttgart · New York

Upregulation of Inflammatory Pathways in Mice with Hypertrophic Cardiomyopathy

S. Gornowitz
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
,
S. S. Raj
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
,
A. Petry
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
,
D. Kracun
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
,
Z. Zhang
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
,
A. Goerlach
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
,
P. Ewert
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
,
J. Schmitt
2   Institute for Pharmacology and Clinical Pharmacology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
C.M. Wolf
1   Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University of Munich, Munich, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
02. Februar 2017 (online)

Objectives: To assess the role of hypoxia-induced transcription factor (HIFs) and reactive oxygen species (ROS) on disease progression in a hypertrophic cardiomyopathy mouse model.

Methods: Mice carrying the human Arg719Trp mutation in the α-cardiac myosin heavy chain gene (αMHC719/+) were compared with wildtypes (WT). Myocardial wall thickness was measured on M-mode in vivo echocardiographic imaging. RNA and protein expression of the myocardial HIF1α as well as components of the nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase was assessed ex vivo by real-time polymerase chain reaction (RT-PCR) and by western blot, respectively. ROS production was measured by electron paramagnetic resonance.

Results: αMHC719/+ mice developed hypertrophic cardiomyopathy. Myocardial HIF1α expression was increased on both the RNA as well as the protein level in αMHC719/+ as compared with WT mice. There was an upregulation of p22phox, an essential component of the NADPH-oxidase, on a protein but not on the RNA-level in αMHC719/+ as compared with WT mice (see [Table 1]). αMHC719/+ mice showed an increase in relative ROS- and superoxide-generation.

Table 1

Results

WT (N = 3–5)

αMHC719/+ (N = 3–5)

p-value

Abbreviations: HIF1α, hypoxia inducible factor 1α; LVWT, left ventricular wall thickness.

Data expressed in mean ± standard deviation.

LVWT (Echocardiography) (mm)

0.73 ± 0.05

1.13 ± 0.08

<0.001

Relative mRNA HIF1α (RT-PCR) (-fold)

1

2.6 ± 0.4

<0.01

Relative mRNA expression p22phox (RT-PCR) (-fold)

1

1.3 ± 0.7

NS

Relative protein expression HIF1α (Western blot) (-fold)

1

3.2 ± 0.4

<0.05

Relative protein expression p22phox (Western blot)(-fold)

1

5.4 ± 0.3

<0.05

Conclusion: Activation of HIFs and increased ROS production suggest the influence of inflammatory pathways on pathogenesis in a murine HCM mouse model. These results might offer new treatment targets in HCM.